Financial News, Analysis and Data, FNArena

FNArena

Financial News, Analysis and Data

Online financial media company focused on Australian equities, with a global perspective

Equity Bottom-Up

Clinuvel Pharmaceuticals / Equity Bottom-Up

<ul><li>Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors just aren't excited</li></ul>

Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors just aren't excited

Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of May 22nd (reported today). The aggregated short interest was USD44.0bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Suncorp, BHP, Computershare, Northern Star Resources, Wesfarmers.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of May 22nd (reported today). The aggregated short interest was USD44.0bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Suncorp, BHP, Computershare, Northern Star Resources, Wesfarmers.


ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

Global Healthcare Analyst

Tina Banerjee

Thematic (Sector/Industry)

<ul>
<li>Samsung Biologics signs manufacturing deals worth over $668M with European pharmaceutical company. Celltrion is acquiring iQone Healthcare, a specialty pharmaceutical distribution company in Switzerland. Kyowa Kirin collaborates for leukemia drug.</li>
<li>Takeda launched Hutchmed’s colorectal cancer drug Fruzaqla in Japan. FDA has turned down Astellas Pharma’s application for label update of geographic atrophy drug Izervay. Lunit is partnering with AstraZeneca.</li>
<li>Yuhan is one step ahead for European approval of Leclaza. HK inno.N signs domestic supply contract for Roche’s influenza treatment, Tamiflu. Beigene settles litigation against generic filer of Brukinsa.</li>
</ul>


Samsung Biologics signs manufacturing deals worth over $668M with European pharmaceutical company. Celltrion is acquiring iQone Healthcare, a specialty pharmaceutical distribution company in Switzerland. Kyowa Kirin collaborates for leukemia drug.
Takeda launched Hutchmed’s colorectal cancer drug Fruzaqla in Japan. FDA has turned down Astellas Pharma’s application for label update of geographic atrophy drug Izervay. Lunit is partnering with AstraZeneca.
Yuhan is one step ahead for European approval of Leclaza. HK inno.N signs domestic supply contract for Roche’s influenza treatment, Tamiflu. Beigene settles litigation against generic filer of Brukinsa.


APAC Healthcare Weekly (Nov 24)- Samsung Biologics, Celltrion, Takeda, Kyowa Kirin, Astellas Pharma

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of Apr 17th (reported today). The aggregated short interest was USD44.8bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Amcor, 4Dmedical Ltd, Telstra, Coles, Telix Pharmaceuticals.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of Apr 17th (reported today). The aggregated short interest was USD44.8bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Amcor, 4Dmedical Ltd, Telstra, Coles, Telix Pharmaceuticals.


ASX Short Interest Weekly (Apr 17th): Amcor, 4Dmedical Ltd, Telstra, Coles, Telix Pharmaceuticals

<ul>
<li>We analyzed the changes in short interest of ASX Stocks as of Apr 10th (reported today). The aggregated short interest was USD42.9bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in BHP, Qbe Insurance, Wesfarmers, Transurban, CAR.</li>
</ul>


We analyzed the changes in short interest of ASX Stocks as of Apr 10th (reported today). The aggregated short interest was USD42.9bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in BHP, Qbe Insurance, Wesfarmers, Transurban, CAR.


ASX Short Interest Weekly (Apr 10th): BHP, Qbe Insurance, Wesfarmers, Transurban, CAR

Australia

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clinuvel Pharmaceuticals (CUV AU)

The Enigma Surrounding Clinuvel

Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors...

FNArena

ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Suncorp, BHP, Computershare, Northern Star...

Ke Yan, CFA, FRM

APAC Healthcare Weekly (Nov 24)- Samsung Biologics, Celltrion, Takeda, Kyowa Kirin, Astellas Pharma

Samsung Biologics secures new manufacturing deals, Celltrion is acquiring iQone Healthcare, Takeda launches colorectal cancer drug in Japan, and...

Tina Banerjee

ASX Short Interest Weekly (Apr 17th): Amcor, 4Dmedical Ltd, Telstra, Coles, Telix Pharmaceuticals

We analyzed ASX short interest report for the past week and highlight short interest changes in Amcor, 4Dmedical Ltd, Telstra, Coles, Telix...

Ke Yan, CFA, FRM

ASX Short Interest Weekly (Apr 10th): BHP, Qbe Insurance, Wesfarmers, Transurban, CAR

We analyzed ASX short interest report for the past week and highlight short interest changes in BHP, Qbe Insurance, Wesfarmers, Transurban, CAR.

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

The Enigma Surrounding Clinuvel

Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors...

FNArena

ASX Short Interest Weekly (May 22nd): Suncorp, BHP, Computershare, Northern Star Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Suncorp, BHP, Computershare, Northern Star...

Ke Yan, CFA, FRM

APAC Healthcare Weekly (Nov 24)- Samsung Biologics, Celltrion, Takeda, Kyowa Kirin, Astellas Pharma

​Samsung Biologics secures new manufacturing deals, Celltrion is acquiring iQone Healthcare, Takeda launches colorectal cancer drug in Japan, and...

Tina Banerjee

ASX Short Interest Weekly (Apr 17th): Amcor, 4Dmedical Ltd, Telstra, Coles, Telix Pharmaceuticals

We analyzed ASX short interest report for the past week and highlight short interest changes in Amcor, 4Dmedical Ltd, Telstra, Coles, Telix...

Ke Yan, CFA, FRM

ASX Short Interest Weekly (Apr 10th): BHP, Qbe Insurance, Wesfarmers, Transurban, CAR

We analyzed ASX short interest report for the past week and highlight short interest changes in BHP, Qbe Insurance, Wesfarmers, Transurban, CAR.

Ke Yan, CFA, FRM

Samsung Biologics secures new manufacturing deals, Celltrion is acquiring iQone Healthcare, Takeda launches colorectal cancer drug in Japan, and...